Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials

類似資料

• Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
  著者:: Bhandari, Sunil, 等
  出版事項: (2020)
• A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial
  著者:: Achebe, Maureen M., 等
  出版事項: (2020)
• A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial
  著者:: Auerbach, Michael, 等
  出版事項: (2019)
• Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
  著者:: Auerbach, Michael, 等
  出版事項: (2021)
• A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia
  著者:: Derman, Richard, 等
  出版事項: (2017)